In vivo and in vitro estrogenic activity of the antidepressant fluoxetine-Reference-Cited by-同舟云学术

In vivo and in vitro estrogenic activity of the antidepressant fluoxetine

Published:2012-08 Issue:1 Volume:34 Page:80-85
ISSN:0890-6238
Container-title:Reproductive Toxicology
language:en
Short-container-title:Reproductive Toxicology

Author:

Müller Juliane C.,Imazaki Pedro H.,Boareto Ana C.,Lourenço Emerson L.B.,Golin Munisa,Vechi Marina F.,Lombardi Natália F.,Minatovicz Bruna C.,Scippo Marie-Louise,Martino-Andrade Anderson J.,Dalsenter Paulo R.

Publisher

Elsevier BV

Subject

Toxicology

Reference64 articles.

1. Sex and depression in the National Comorbidity Survey: II. Cohort effects;Kessler;Journal of Affective Disorders,1999

2. Depressive symptoms among pregnant women screened in obstetrics settings;Marcus;Journal of Women's Health,2003

3. Prevalence of depression during pregnancy: systematic review;Bennett;Obstetrics and Gynecology,2004

4. Prevalence of postpartum depression and associated factors;Moraes;Revista Saude Publica,2006

5. Practice guideline for the treatment of patients with major depressive disorder;American Psychiatric Association,2010

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antidepressants – The new endocrine disruptors? The case of crustaceans;Molecular and Cellular Endocrinology;2024-04

2. Nanoplastics increase in vitro oestrogenic activity of neurotherapeutic drugs;Archives of Industrial Hygiene and Toxicology;2024-03-01

3. The antidepressant fluoxetine (Prozac®) modulates serotonin signaling to alter maternal peripartum calcium homeostasis;Scientific Reports;2023-12-09

4. Maternal serotonin: implications for the use of selective serotonin reuptake inhibitors during gestation;Biology of Reproduction;2023-04-25

5. The antidepressant fluoxetine (Prozac®) modulates estrogen signaling in the uterus and alters estrous cycles in mice;Molecular and Cellular Endocrinology;2023-01